Morsani College of Medicine
Department of Molecular Medicine
Joint and Affiliate Faculty
Post-Doctorates / Research Associates
How To Apply
Master's of Science Program
Allergy, Immunology and Infectious Diseases
USF Health Byrd Alzheimer's Institute
Children's Research Institute (CRI)
Center for Drug Discovery and Innovation
H. Lee Moffitt Cancer Center
James A Haley Veteran's Hospital
Bay Pines VA Healthcare System
Caralina Marin De Evsikova,
Assistant Professor, COLLEGE OF MEDICINE MOLECULAR MEDICINE
The early developmental environment plays a pivotal role in susceptibility to adulthood metabolic disease, such as obesity and diabetes. The long-term goal of this project is to understand how the maternal and embryonic environment alters gene expression, which ultimately leads to disease, via epigenetics. Epigenome of each individual is established during the egg-to-embryo transition, which is sensitive to teratogens, such as alcohol, bisphenol A, or dietary exposures. To identify the role of epigenetics in metabolic disease, I am using a naturally occurring “epigenetic barometer” allele (viable yellow) of the Agouti gene in mice, whose expression is controlled by methylation levels. Nutrigenomics & Healthspan. My long-term goal is to develop new mouse models of adult-onset metabolic diseases by monitoring in vivo physiology coupled with quantitative molecular genetics to detect genes and pathways involved with weight gain. This approach has been successful in identifying changes in eating, activity, and loss of circadian rhythms underlying “normal” weight fluctuations from across the lifespan.
View Our Full Calendar
Our lab is focused on understanding palmitoylation, a post-translational modification of Ras (an oncogene implicated in ~30% of all cancers, and up to 90% in specific cancer types) involved in its localization to the plasma membrane where Ras elicits a majority of its activity.
My project focuses on understanding the regulation of Ras palmitoylation in three ways. Initially, I used a candidate based approach to screen for the enzyme responsible for Ras depalmitoylation. More recently, I have been screening mutants of the enzyme that palmitoylated Ras to see the effect of the mutations on activity, and finally, I will perform high-throughput inhibitor screens in an attempt to identify inhibitors of palmitoylation.
Technical and Paraprofessional, COLLEGE OF MEDICINE SURGERY
nanoparticles for targeting gene or drug delivery
hydrogel for tissue engineering
nanoparticles for diagnostics